Genefitletics, a techbio company founded in the year 2020, is unlocking the potential of mitochondrial reprogramming to drive the future of early diagnostics.

The company has developed & commercialised a cellular energetics platform that apply principles of physics on human biological systems & overlays complex mathematical models on 10 million plus cellular data extracted from an individual’s biological sample to identify cellular stressors elevating energy resistance(eR).

These energetic dysregulations are mapped to cellular hallmarks of degenerative diseases & cancer, enabling earlier diagnosis than currently possible with MRI, PET, biopsy, routine plasma level investigations or mutation-based approaches. 

Rather than fixing mutations or engineering tissues, the company’s proprietary computation model driven regenerative therapeutics remodels the cell's bioelectric network to reprogram cancer/dysfunctional cells & restore cell collective intelligence.

The platform allows patients & healthcare practitioners to longitudinally examine the connection between cellular stress, energetic cascades & disease onset & track & improve the real time impact of biotherapeutics on improvement in the cellular stressors hallmarks.

The Genefitletics team is made up of scientists, engineers, researchers, and entrepreneurs, who all have a shared lifelong vision of empowering patients/customers unlock their health potential 


Genefitletics

Org chart

Teams

Offices

Genefitletics

Org chart

Teams

Offices

Related companies